Interestingly, Zhao et al. have demonstrated that pharmacological reduction of leptin levels under obese conditions, through the use of neutralizing antibodies, restores leptin sensitivity, reduces food intake, and protects mice from diet-induced obesity [37]. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.